BUY Glenmark Pharmaceuticals — Manas Jaiswal, 27 Oct 2026

BUYGlenmark Pharmaceuticals

Glenmark Pharmaceuticals share price target & all analyst calls

byManas JaiswalHorizon: NA (inferred Swing (≤2wk))27 Oct 2026via CNBC Awaaz.

Entry₹2,214.7Inferred

Target₹2,300

Total upside +3.85%

Stop loss₹2,189-1.16% risk

CMP₹2,257.3Just now

Active+1.92%+1.89%upside left 13d left

Follow Manas Jaiswal for new calls(30% target hit, 380 closed calls)Get alerts Watch GLENMARK for new buy/sell callsGet alerts See 1 other Swing call on GLENMARK See 129 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 27 Oct, 1:50 pm IST

2 supporting1 neutral1 opposing

Supports the BUY call (2)

1 other SEBI-registered advisor has an active swing BUY call on this stock

Advisor consensus · same horizon·13 Oct · 2w ago

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·23 Sept · 1mo ago

Neutral / worth noting (1)

Q2 FY27 results scheduled — board meets 05 Nov 2026

BSE · Board Meeting·In 9 days

Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·27 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Manas Jaiswal

Every call and its outcome